140 related articles for article (PubMed ID: 12692746)
1. ALLHAT: definitive answers or continuing uncertainty?
Sever P;
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):3-5. PubMed ID: 12692746
[No Abstract] [Full Text] [Related]
2. ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
Elliott WJ
Am J Hypertens; 1996 Apr; 9(4 Pt 1):409-11. PubMed ID: 8722446
[No Abstract] [Full Text] [Related]
3. ALLHAT: a saga of missed opportunities.
McInnes GT
J Hum Hypertens; 2003 Jun; 17(6):373-7. PubMed ID: 12764398
[No Abstract] [Full Text] [Related]
4. [ALLHAT].
Ando K
Nihon Rinsho; 2006 Aug; 64 Suppl 6():402-7. PubMed ID: 16981570
[No Abstract] [Full Text] [Related]
5. The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.
Hebert LA; Rovin BH; Hebert CJ
Nat Clin Pract Nephrol; 2007 Feb; 3(2):60-1. PubMed ID: 17251990
[No Abstract] [Full Text] [Related]
6. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
Beevers DG; Lee KW; Lip GY
J Hum Hypertens; 2003 Jun; 17(6):367-72. PubMed ID: 12764397
[No Abstract] [Full Text] [Related]
7. A family physician questions the conclusions from ALLHAT.
Standridge JB
Am J Hypertens; 2004 Apr; 17(4):361-5. PubMed ID: 15062891
[TBL] [Abstract][Full Text] [Related]
8. [ALLHAT--remaining questions await answers].
Nilsson PM
Lakartidningen; 2004 Jan; 101(3):220, 223; discussion 224-7. PubMed ID: 14763096
[No Abstract] [Full Text] [Related]
9. [After the ALLHAT trial, what do we know about treatment for hypertension that we did not know before?].
González-Juanatey JR
Rev Esp Cardiol; 2003 Jul; 56(7):642-8. PubMed ID: 12855144
[No Abstract] [Full Text] [Related]
10. ALLHAT in perspective: implications to clinical practice and clinical trials.
Yusoff K
Med J Malaysia; 2005 Jun; 60(2):239-45. PubMed ID: 16114170
[TBL] [Abstract][Full Text] [Related]
11. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?
Nicholls MG
J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907
[No Abstract] [Full Text] [Related]
12. Results of ALLHAT: is this the final answer regarding initial antihypertensive drug therapy?
Moser M
Arch Intern Med; 2003 Jun; 163(11):1269-73. PubMed ID: 12796062
[No Abstract] [Full Text] [Related]
13. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
Berecek KH; Farag A; Bahtiyar G; Rothman J; McFarlane SI
Curr Hypertens Rep; 2004 Jun; 6(3):212-4. PubMed ID: 15128474
[No Abstract] [Full Text] [Related]
14. [Editorial: hypertensiology].
Hitzenberger G
Wien Med Wochenschr; 2008; 158(13-14):357-8. PubMed ID: 18677584
[No Abstract] [Full Text] [Related]
15. The VA HDL intervention trial: clinical implications.
Rubins HB; Collins D; Robins SJ
Eur Heart J; 2000 Jul; 21(14):1113-5. PubMed ID: 10924289
[No Abstract] [Full Text] [Related]
16. Taking risks: primary prevention of cardiovascular events.
Vallance P
N Z Med J; 2001 May; 114(1132):223-4. PubMed ID: 11453356
[No Abstract] [Full Text] [Related]
17. The hidden effects of antihypertensive and lipid-lowering agents on the prevention and regression of atherogenesis: new management strategies.
Weinberg MS
R I Med; 1995 Mar; 78(3):78-81. PubMed ID: 7734758
[No Abstract] [Full Text] [Related]
18. Management of hyperlipidaemia: postscript.
Sum CF; Tan CE; Chew LS
Singapore Med J; 1995 Oct; 36(5):538. PubMed ID: 8882543
[No Abstract] [Full Text] [Related]
19. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications.
Oparil S
Hypertension; 2003 May; 41(5):1006-9. PubMed ID: 12695423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
